Clomid: A Potential Treatment for Hypogonadism or Low Serum Testosterone Levels

Clomiphene citrate is an oral medication that blocks estrogen feedback at the hypothalamus and pituitary, so the body releases more LH and FSH and the testicles are signaled to make more testosterone of their own. In men with low serum testosterone this is off-label prescribing: the FDA approval for clomiphene citrate covers ovulation induction in women, not male hypogonadism. It comes up most often for men who want to keep producing sperm, because testosterone given from the outside suppresses the same signal.

What is Clomid, and what is it actually approved for?

Clomid is a brand name for clomiphene citrate. Its FDA-approved indication is ovulation induction in women who are not ovulating. There is no approved indication in men, for low testosterone or for anything else, so a prescription written for a man is an off-label prescription.

Off-label prescribing is legal and ordinary in medicine. It means a licensed prescriber has decided, for a specific patient, that the published literature and that patient's situation justify using a drug outside its labeling. It also means the FDA has not reviewed data for that use, which is why the framing on this page is "one option a prescriber may consider" rather than a recommendation. Whether clomiphene is appropriate at all, and at what dose, are the prescriber's decisions and not something a pharmacy or a website can make for you.

Bayview is a 503A compounding pharmacy in Warwick, Rhode Island, and prepares hormone-related medications only on a prescription written for a named patient. Our hormone replacement therapy service exists to fill prescriptions your own clinician writes, not to direct treatment.

How does clomiphene act on testosterone production?

Testosterone production runs on a feedback loop. The hypothalamus releases GnRH, the pituitary responds with luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and the testicles respond to LH by producing testosterone and to FSH by supporting sperm production. Some of that testosterone is converted to estradiol, and estradiol tells the hypothalamus and pituitary to ease off.

Clomiphene is a selective estrogen receptor modulator, or SERM. It occupies estrogen receptors in the hypothalamus and pituitary and blocks that "ease off" message. With the brake released, GnRH, LH and FSH rise, and the testicles receive a stronger signal.

That is the structural difference from testosterone therapy. A SERM acts upstream, on the signal, so whatever testosterone appears is produced by your own testicles. Compounded testosterone for men acts downstream, supplying the hormone directly. Testosterone is a controlled substance, dispensed only on a prescription written for a named patient, and controlled substances are not shipped to New York addresses.

Why would a man choose clomiphene instead of testosterone?

The usual reason is fertility. Exogenous testosterone raises serum levels but also signals the pituitary to stop sending LH and FSH, and without that signal the testicles reduce or stop sperm production and often shrink over time. For a man who wants children now or later, that is a real trade-off rather than a footnote.

Because clomiphene works through the pituitary instead of bypassing it, LH and FSH go up rather than down, and spermatogenesis is not suppressed by the drug itself. That single difference is why clomiphene and its isomer come up in men's health at all. If you are weighing the two approaches, our complete overview of testosterone replacement therapy covers what conventional TRT involves in more detail.

The second reason is reversibility. A SERM is stopped and the feedback loop returns to its own baseline. Testosterone therapy, once started, is often continued indefinitely, and restarting natural production after long suppression can take months, with no certainty of returning to the original baseline.

Clomiphene, enclomiphene and testosterone compared

Regulatory status is the column to read first. None of the three options below is an FDA-approved product for male hypogonadism as prepared by a compounding pharmacy.

Clomiphene citrate is FDA-approved only for ovulation induction in women, which is why its row reads off-label rather than approved. Enclomiphene has been studied in men but has not been approved as a finished drug product, so a compounded enclomiphene capsule is not an approved product either. Compounded testosterone is prepared for an individual patient and is likewise not FDA-approved, although commercially manufactured testosterone products are.

What does the evidence on clomiphene for low testosterone show?

The published literature in men is smaller and weaker than the literature behind testosterone replacement. It consists largely of small open-label studies, retrospective chart reviews and case series, with some randomized comparisons of limited size and duration. Serum testosterone rising on treatment is the outcome most often reported.

What is thinner is long-term data: how symptoms respond over years, how the approach performs against testosterone therapy head to head, and what happens with extended use. Because we cannot cite a number we are confident in, this page does not give one. A urologist or endocrinologist who follows this literature is the right person to tell you what it supports for your situation.

What side effects and cautions are reported with clomiphene?

Visual disturbances are the adverse effect most specific to clomiphene. Blurred vision, light sensitivity, floaters or afterimages have been reported, and the drug's labeling in women instructs that treatment be stopped and an eye examination arranged if visual symptoms appear. Tell your prescriber promptly about any change in vision.

Mood changes, including irritability and low mood, are reported as well. Other reported effects include headache, nausea, breast tenderness or gynecomastia, and changes in liver-related laboratory values. Men with a history of liver disease, an eye condition, or a hormone-sensitive cancer need that history on the table before anything is prescribed.

Clomiphene raises estradiol as well as testosterone, since more testosterone means more substrate for aromatase. Some men tolerate that without difficulty and some do not, which is part of why prescribers order follow-up bloodwork. What is checked, and how often, is the prescriber's call.

Who is not a candidate for clomiphene?

Clomiphene is not for men whose low testosterone comes from primary testicular failure. If the testicles themselves cannot respond, raising LH and FSH has nothing to act on, which is why a workup distinguishes primary hypogonadism from secondary (pituitary or hypothalamic) hypogonadism before treatment is chosen.

It is also not appropriate for anyone with a known hypersensitivity to it, and prescribers generally avoid it in liver disease, in undiagnosed abnormal bleeding, and where there is an untreated pituitary lesion. Existing eye disease deserves a conversation given the visual effects above.

How is enclomiphene different from clomiphene?

Clomiphene citrate is a mixture of two isomers: enclomiphene, the trans isomer, which carries most of the estrogen-blocking activity at the pituitary, and zuclomiphene, the cis isomer, which is more estrogenic and clears from the body slowly. The interest in separating them is that enclomiphene alone delivers the pituitary effect without the accumulating zuclomiphene fraction.

Enclomiphene has been through clinical trials in men with secondary hypogonadism but has not been approved by the FDA as a finished drug product. It is available in the United States only as a compounded preparation. Bayview prepares compounded enclomiphene capsules in the strength a prescriber specifies, under USP 795 non-sterile compounding.

What else might a prescriber look at for low testosterone symptoms?

Low energy, low libido and poor concentration are not specific to testosterone. Thyroid function, sleep apnea, medication side effects, depression and iron status all produce overlapping symptoms, and a workup that skips them can point at the wrong target. Where thyroid hormone is the issue, compounded thyroid (T3/T4) capsules are a different preparation with a different purpose.

Erectile difficulty often travels with low testosterone but is not always caused by it, and it is treated on its own track. Sildenafil is the short-acting PDE5 inhibitor most men have heard of, compounded here as troches or rapid dissolve tablets when a swallowed tablet is not workable.

Some men are prescribed tadalafil instead, a longer-acting PDE5 inhibitor taken on a different schedule. Which one, if either, belongs in the plan is a clinical decision.

For background on that class of medication, our article on Viagra and how PDE5 inhibitors act covers where they fit and what they do not address.

For the wider hormonal picture, including what a hormone panel looks at and how prescribers read it, balancing your hormones with hormone replacement therapy is the companion piece to this one.

What does Bayview compound for this?

Bayview prepares oral enclomiphene capsules to the strength written on the prescription, along with the rest of the hormone replacement therapy preparations in our catalog: testosterone for men as a topical or oral form, testosterone for women, bi-est and progesterone, estradiol topical and vaginal preparations, vaginal estriol and DHEA. Every one of them is made on a prescriber's order for a named patient, not stocked as a product you can buy.

Compounding is how a prescriber gets a strength or a dose form that is not commercially available. If you want to see what else is prepared here, the searchable catalog of compounded medications lists each preparation with its route and starting price.

Compounded enclomiphene capsules start at $160 for a typical supply, and compounded preparations are not billed through insurance, because a compounded preparation has no NDC number for a plan to adjudicate. You pay the pharmacy directly. Questions about pricing, ordering, and the states where Bayview is licensed to ship are answered on our frequently asked questions page.

Talk to your prescriber

If you have symptoms of low testosterone, the first step is measurement, not medication: a morning total testosterone drawn on more than one occasion, with LH, FSH, prolactin and estradiol as the picture requires. Those results are what separate primary from secondary hypogonadism, and that distinction is what determines whether a SERM has any role at all.

Bring the fertility question up early, because it changes the conversation. Tell your clinician whether you want children in the future, and ask directly how each option would affect that. If your prescriber decides a compounded preparation is appropriate, they can send the prescription to Bayview and our pharmacists will prepare it to their specification and answer your questions about storage and use.